Pages that link to "Q26782555"
Jump to navigation
Jump to search
The following pages link to The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD) (Q26782555):
Displaying 13 items.
- Effects of AP‑1 and NF‑κB inhibitors on colonic endocrine cells in rats with TNBS‑induced colitis (Q37083066) (← links)
- Enteroendocrine cells, stem cells and differentiation progenitors in rats with TNBS-induced colitis (Q37426690) (← links)
- Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats (Q37707717) (← links)
- Abnormal differentiation of stem cells into enteroendocrine cells in rats with DSS-induced colitis (Q37720153) (← links)
- Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease (Q38622923) (← links)
- Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome (Q40277440) (← links)
- Anxiety, Depression, and the Microbiome: A Role for Gut Peptides (Q47709491) (← links)
- Peptide YY Causes Apathy-Like Behavior via the Dopamine D2 Receptor in Repeated Water-Immersed Mice. (Q50079188) (← links)
- The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response (Q64097633) (← links)
- Neuropeptide Y receptor interactions regulate its mitogenic activity (Q90024712) (← links)
- Comprehensive analysis of gene expression profiles provides insight into the pathogenesis of Crohn's disease (Q90278080) (← links)
- Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases (Q90325387) (← links)
- Pharmacological inhibition of NPY receptors illustrates dissociable features of experimental colitis in the mouse DSS model: Implications for preclinical evaluation of efficacy in an inflammatory bowel disease model (Q92340249) (← links)